Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation.
Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation. — المؤلف: Ha, Boram — Radiation oncology (London, England) 20190201
- المؤلف
- Ha, Boram
- النشر
- Radiation oncology (London, England) 20190201
- الوصف
- 4 p.
- الموضوعات
- Adenocarcinoma؛ Adult؛ Aged؛ Aged, 80 and over؛ Dose Fractionation, Radiation؛ Follow-Up Studies؛ Humans؛ Male